Case report shows successful healing of nonunion in a patient, suggesting biomimetic hematoma may treat resistant cases.
A 49-year-old male smoker with no comorbidities presented with a tibial plafond fracture treated operatively. Complications resulted to an infected nonunion, requiring 20 surgeries over 3 years. Examination revealed a malaligned hypertrophic nonunion with osteomyelitis requiring extensive reconstruction. Deformity was corrected with a Taylor Spatial Frame, followed by the implantation of a biomimetic hematoma scaffold delivering recombinant human bone morphogenetic protein-2 (rhBMP-2) into the debrided defect, alongside Cerement G to control infection. At 6 months, the patient achieved complete bony union without recurrence of infection, allowing Taylor Spatial Frame removal. The biomimetic hematoma enabled successful healing using a low-dose rhBMP-2, highlighting its potential for treatment-resistant nonunions.
No takes yet. Share an insight, caveat, or question.
Maestas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: